Cooperative Agreement U48DP006963
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $499K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
- This federal Cooperative Agreement award, valued at $350,000.00, is funded by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award, with a period of performance from September 30, 2025 to September 29, 2028, supports Clemson University in evaluating the Health Extension for Diabetes Program, a community-clinical linkage program. The objective of the project is to implement evidence-based strategies to...
- This Cooperative Agreement award, valued at $492,348.00 and awarded by the National Center for Chronic Disease Prevention and Health Promotion, is part of the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award will support the University of Pittsburgh in implementing evidence-based lifestyle change interventions to improve health outcomes related to diabetes. The project aims to decrease type 2 diabetes risk, improve self-care practices, enhance diabetes care...
- This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) provides $350,000.00 in funding to the University of Illinois to develop strategies for leveraging Federally Qualified Health Centers (FQHCs) as trusted community partners to improve diabetes management. The project aims to enhance diabetes prevention, self-care practices, and health equity by implementing evidence-based...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) supports the establishment of a nationwide diabetes surveillance system for youth and young adults. The $500,000 award, with a performance period from September 30, 2025 to September 29, 2029, will fund research on the incidence, prevalence, risk factors, disparities, and social determinants of health related to diabetes in this...
- This $699,999 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the NYU LANGONE HEALTH COORDINATING CENTER FOR CASSIDY (NYU COC) located in New York. The award, effective from September 30, 2025 to September 29, 2029, funds research, surveillance, community interventions, and health system improvements targeting priority populations experiencing diabetes-related health...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...
- This $644,524 Project Grant award from the National Science Foundation's (NSF) Integrative Activities (CFDA 47.083) program supports a collaborative research project between Howard University and North Carolina A&T State University. The project aims to identify the dynamic structure of the progression to type 2 diabetes (T2D) using mathematical models. Key activities include: Constructing a theoretical threshold to distinguish between diabetes and non-diabetes states, validated using...
- The Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY) is a $498,891 Cooperative Agreement awarded on Sep 30, 2025 by the National Center for Chronic Disease Prevention and Health Promotion, a division of the Centers for Disease Control and Prevention (CDC). This 4-year award (through Sep 29, 2029) supports Geisinger Clinic, a non-profit healthcare organization in Pennsylvania, in implementing evidence-based strategies to address diabetes...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This $344,301 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283), supports the Virgin Islands Department of Health's efforts to address significant health disparities related to tobacco use and diabetes in the U.S. Virgin Islands. The key initiatives include implementing self-management programs for diabetes prevention, organizing community walks, training healthcare providers in tobacco...